[{"Assets_0_Q3_USD":"12618745000.0","CIK":"875320","CommonStockSharesIssued_0_Q3_shares":"256206000.0","CommonStockSharesOutstanding_0_Q3_shares":"256206000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"3.3","EarningsPerShareBasic_3_Q3_USD":"6.08","EarningsPerShareDiluted_1_Q3_USD":"3.28","EarningsPerShareDiluted_3_Q3_USD":"6.03","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"1648507000.0","NetIncomeLoss_1_Q3_USD":"851928000.0","NetIncomeLoss_3_Q3_USD":"1571990000.0","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_Q3_USD":"1984164000.0","RevenuesConverted_3_Q3_USD":"5501839000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q3_USD":"9530708000.0","Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"259707000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"260877000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"257876000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"258740000.0","filed":"20211103","footnote":null,"form":"10-Q","fp":"Q3","fy":"2021.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20210930","qtrs":"0","uom":"USD"}]